Efficacy and Safety of Latanoprost/Timolol Fixed-Dose Combination in Glaucoma Treatment: A 20-Year Review

• by Jose Martinez-de-la-Casa, Pedro Corsino, Andrzej Grzybowski, Andrew Tatham, Shivani Ohri Vignesh, Tarek Hassan

• January 8, 2026

Small Copy Number Neutral Intrachromosomal Translocation of PAX6 and Aniridia

• by Linda M. Reis, Jared Tomei, Ryan Gallagher, Andrea Matter, Joseph Carroll, Ulrich Broeckel, Elena V. Semina

• June 1, 2026

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

• by Andrea Surnit

• July 8, 2026

• 3 min

Assessment of the Quality and Trustworthiness of Glaucoma-Related Videos on Douyin and Bilibili: A Cross-Sectional Content Analysis

• by Dangdang Wang, Yanyu Pu, Yunfei Li, Yang Peng, Yuyan He, Xi Gao, Huiyu Zhu, Wenyi Wang, Shaowen Du, Hong Li

• March 1, 2026